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Cerebral malaria (CM) is a serious complication of Plasmodium
falciparum infection associated with cerebral vasculopathy, high mortal-
ity, and risk of neurological sequelae. In humanCM, infected RBCs adhere
to the brain endothelium and occlude the cerebral blood vessels causing
cerebral vascular damage, impaired perfusion, vasospasms, vasocon-
striction, and inﬂammation. Vasoactive factors, including endothelin
(ET-1), have become increasingly important in the pathogenesis of
CM. We previously demonstrated that antagonism of the ET-1 type A
receptor (ETA) improved survival and attenuated brain hemorrhage in
murine CM. In this study we tested the hypothesis that ET-1 contributes
to CNS inﬂammation and BBB disruption in experimental CM (ECM)
via its actions on ETA. To test this hypothesis we used our model
of Plasmodium berghei ANKA (PbA) infection of C57BL/6 mice. PbA-
infection resulted in activation of monocytic CNS cells, microglia, which
are important in inﬂammation. ECMwas also associatedwith an increase
in brain microvascular endothelial cell activation which is critical for
leukocyte adhesion. Treatment of PbA-infected mice with ETA receptor
antagonists attenuated the increase in microglial and endothelial cell
activation, suggesting that ET-1 contributes to CNS inﬂammation during
ECM. Furthermore, leakage of Evans blue bound-albumin into the brain
was reduced in ECMmice receiving ETA receptor antagonism, providing
further support that disruption of the BBB and inﬂammation during ECM
result, in part, from increases in ET-1 and its actions on the ETA receptor.
Together theseﬁndings illustrate a role for ET-1 in the immunopathology
and vasculopathy associated with ECM, and highlight the peptide as a
potential target for adjunctive therapy for the protection of neurological
function in patients with CM.
doi:10.1016/j.lfs.2013.12.045
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Sepsis, a heterogeneous class of syndromes, is associated with the
development of progressive damage in multiple organs. The path-
ogenesis of sepsis-induced myocardial dysfunction is still not fully
understood. The present study examined the alteration of key angio-
genic signaling pathway mediated by the vascular endothelial growth
factor (VEGF) in sepsis heart and the effects of dual endothelin (ET)
antagonism on it. Normal male Wistar rats at age 8 wks were ad-
ministeredwith lipopolysaccharide (LPS: 15 mg/kg) and then sacriﬁced
at different time points (1 h, 3 h, 6 h and 10 h). Some rats without
LPS administration was considered as the control group. Some of
the LPS-administered rats were treated with dual endothelin blocker
(SB209670, 1 mg/kg body weight) for 6 h and then sacriﬁced. Admin-
istration of LPS resulted in increases in the serum levels of TNF-alpha
(maximum at 1 h after LPS, 1200-fold compared to control rats), and
ET-1 (maximum at 3 h after LPS, 25-fold compared to control rats). At
6 h after LPS administration, we found decreased percent of fractional
shortening in the heart. The expression of VEGF, and its downstream
angiogenic signaling molecules namely eNOS and NO, was signiﬁcantly
increased in heart tissues after LPS administration compared to the
control group which was also accompanied by increased cardiac ET-1
level. Dual endothelin blockade for 6 h further upregulated the VEGF
angiogenic signaling in endotoxemic heart.
doi:10.1016/j.lfs.2013.12.046
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Purpose: Endothelin-1 (ET-1) is overexpressed in breast carcino-
mas, while circulating levels of its precursor (Big ET-1) have also
been found elevated. In the present study, we evaluated plasma ET-1
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